Delivery Order SPE2DB22D2007-SPE2DB24FJ2YX
Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,653.80 firm fixed-price delivery order has a completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $4,647.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,288,309 units of MONOVISC 88 MG/4 ML SYRINGE 4ML. This contract has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of a pharmaceutical product called Monovisc 88 mg/4 ml syringe, 4 ml. The contract has a ceiling value of $10,225.88 and is a delivery order contract with a firm fixed price pricing type. The award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $7,229.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "MONOVISC 88 MG/4 ML SYRINGE 4ML" and has a firm fixed price pricing type. The contract is not set aside and has an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award, valued at $17,188.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $4,647.12 by the Defense Logistics Agency (DLA) to provide MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,016.60 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through March 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product, with a completion date of June 10, 2024. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December...